| Overall (N = 175)a |
---|---|
Gender | |
 Cisgender man | 117 (66.9%) |
 Cisgender woman | 41 (23.4%) |
 Nonbinary, Genderqueer, or Other | 3 (1.7%) |
 Transgender woman | 8 (4.6%) |
 Unknown or not disclosed | 6 (3.4%) |
Age | |
 Less than 30 years | 35 (20.0%) |
 30–39 years | 54 (30.9%) |
 40–49 years | 64 (36.6%) |
 50–59 years | 19 (10.9%) |
 60 years or older | 3 (1.7%) |
Race and Ethnicity | |
 Black | 44 (25.1%) |
 Hispanic | 16 (9.1%) |
 Other | 23 (13.1%) |
 White (non-Hispanic) | 92 (52.6%) |
Housing Statusb | |
 Stable | 51 (29.1%) |
 Unstable | 124 (70.9%) |
Injection Drug Usec | |
 Injection drug use | 72 (41.1%) |
 No injection drug use | 79 (45.1%) |
 Missing | 24 (13.7%) |
Substance Usec | |
 Methamphetamine | 133 (76.0%) |
 Heroin | 65 (37.1%) |
 Cocaine or crack cocaine | 42 (24.0%) |
 Hazardous alcohol use | 30 (17.1%) |
 Marijuana | 86 (49.1%) |
 Prescription-type opioids | 2 (1.1%) |
 Benzodiazepine | 13 (7.4%) |
 No substance use | 12 (6.9%) |
Psychiatric diagnosesc | |
 Depression | 115 (65.7%) |
 Bipolar or related disorders | 35 (20.0%) |
 Anxiety | 64 (36.6%) |
 Post-Traumatic Stress Disorder | 40 (22.9%) |
 Schizophrenia spectrum or other psychotic disorders | 46 (26.3%) |
 Neurodevelopmental disorders (excluding ADHD) | 4 (2.3%) |
 Attention Deficit Hyperactivity Disorder | 12 (6.9%) |
 Personality disorders | 10 (5.7%) |
 Feeding and eating disorders | 4 (2.3%) |
 No psychiatric diagnosis | 25 (14.3%) |